Details for New Drug Application (NDA): 050131
✉ Email this page to a colleague
NDA 050131 describes BICILLIN L-A, which is a drug marketed by King Pharms Llc and Wyeth Ayerst and is included in two NDAs. It is available from two suppliers. Additional details are available on the BICILLIN L-A profile page.
The generic ingredient in BICILLIN L-A is penicillin g benzathine. There are ninety-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the penicillin g benzathine profile page.
The generic ingredient in BICILLIN L-A is penicillin g benzathine. There are ninety-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the penicillin g benzathine profile page.
Summary for 050131
| Tradename: | BICILLIN L-A |
| Applicant: | Wyeth Ayerst |
| Ingredient: | penicillin g benzathine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050131
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 300,000 UNITS/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
